By the end of this topic, the student should be able to:
"…harm reduction as a philosophy shifts the moral context in health care away from the primary goal of fixing individuals towards one of reducing harm."
On a daily basis, efforts and interventions to reduce harm occur across health professions.
When a pharmacist places a “Take with food” sticker on a prescription drug, they are engaging in a harm reduction activity.
Harm reduction approaches acknowledge that:
Many associate harm reduction with illicit drugs and drug use. However, “harm reduction focusses on introducing practices that mitigate harms, not only of substance use, but also of the historical, socio-cultural and political factors related to responses to substance use” (Pauly, 2008).
The legal status of certain drugs, stigma, and lack of understanding about substance use led to a historical focus on prevention and treatment for substance use and substance users.
By definition:
However, these approaches failed to recognize that prevention and treatment are often ineffective. In these situations, interventions are often necessary. Interventions to reduce harms associated with ongoing substance use include, but are not limited to:
Certain interventions, such as opioid agonist therapy (OAT), can be labeled both harm reduction and/or treatment, depending on the individual.
Attitudes and access to harm reduction services change and evolve over time.
For example, InSite, Canada’s first supervised injection site, established in 2003, faced multiple legal challenges at both the provincial and federal level.
In 2020, just nine years after the Supreme Court of Canada allowed InSite to continue to operate, Canada had over three dozen approved or pending supervised consumption/overdose prevention sites.
Morals are derived from a community, group, religion etc. but are also one’s own sense of right or wrong (McKay & Whitehouse, 2015).
Ethics are rules from an external source, adopted by the individual. Professional ethics are adopted by the members of a profession and help to guide decision making in their work (Canadian Nurses Association, 2017).
Moral uncertainty occurs when someone suspects but is unsure whether they are facing a moral or ethical dilemma, and may not know what moral or ethical principles are being challenged.
A moral dilemma exists when there is a clear conflict between two or more moral or ethical principles — there is no fully satisfactory outcome, i.e., some compromise will occur.
Moral distress occurs when one feels that there is a right course of action, but due to professional, institutional, societal constraints, that action can not be taken.
For health and social service professionals the following can complicate professional decision making about harm reduction activities:
Most professional codes of ethics and standards do not address or provide guidance on “harm reduction” specifically, so ethics and standards must be applied to harm reduction.
monkeybusinessimages/iStock
The Canadian Nurses Association publishes the “Code of Ethics for Registered Nurses” (last edition was 2017).
monkeybusinessimages/iStock
The Canadian Association of Social Workers (CASW) publishes several policy and position statements on their website, including supporting harm reduction as a key part of federal drug policy.
SerhiiBobyk/iStock
At the national level, the Canadian Pharmacists Association (CPhA) publishes a series of topics in their “Advocacy” section. With respect to the opioid crisis, CPhA outlines actions pharmacists can take to tackle the crisis, including decreasing inappropriate opioid use and opioid use monitoring.
Like the other professions, most Provincial codes of ethics/standards do not specifically address harm reduction, however many provide resources to members about harm reduction, particularly naloxone, that became available for distribution from pharmacies in 2016.
Now that you have reviewed this content, consider the following scenarios:
It’s Friday night and you are just about to close for the weekend when a patient enters your pharmacy and requests a refill for his opioid prescription. You tell him that there are no repeats for his prescription, but he asks you for enough medication to get through the weekend. Recently, this patient has been 2-3 days early in refilling his prescription. He states that he is already experiencing severe pain as well as symptoms of opioid withdrawal. He has an appointment with his prescriber first thing Tuesday morning and there are no other accessible medical services in this rural area.
What course of action do you take?
Is this an example of a moral or ethical dilemma?
You are working in a rural nurse-led clinic (you could be a Nurse Practitioner or an RN who is not an NP). The regular clinic physician you consult with is not in the clinic today. A patient well known to the clinic staff and also known to use unregulated drugs has come in for pain medication – an opioid. This happens on a regular basis. In your assessments of the patient over time, you have felt that the patient’s pain is not at all well managed. However, you also are aware that the physician you consult with is very wary of prescribing opioids to people who use unregulated drugs. You have tried to advocate for the patient several times with no success. You feel a great deal of anxiety as soon as you see this patient come into the clinic. Today the patient is very angry and agitated (adapted from Smye, 2020).
What course of action do you take?
Consider the guidance and standards described above, and consult the guidance of your professional associations to help with your decision.
Canadian Association of Social Workers. (n.d.). Policy and position statements. https://www.casw-acts.ca/en/policy
Canadian Drug Policy Coalition. (n.d.). Harm reduction. https://drugpolicy.ca/our-work/issues/harm-reduction/
Canadian Nurses Association. (2017). Code of ethics for registered nurses. https://www.cna-aiic.ca/nursing-practice/nursing-ethics
Canadian Council for Practical Nurse Regulators. (2013). Standards of practice for licensed practical nurses in Canada. https://www.clpna.com/wp-content/uploads/2013/02/doc_CCPNR_CLPNA_Standards_of_Practice.pdf
Canadian Pharmacists Association. (n.d.). Advocacy—Opioid crisis. https://www.pharmacists.ca/advocacy/opioid-crisis/
College of Nurses of Ontario. (2018). Entry-to-practice competencies for registered nurses. http://www.cno.org/globalassets/docs/reg/41037-entry-to-practice-competencies-2020.pdf
InSite for Community Safety. (n.d.). The legal story. http://www.communityinsite.ca/legal.html
Kälvemarka, S., Höglund, A. T., Hansson, M. G., Westerholm, P., & Arnetz, B. (2004). Living with conflicts–Ethical dilemmas and moral distress in the health care system. Social Science and Medicine, 5(6), 1075–1084. http://doi.org/10.1016/s0277-9536(03)00279-x
McKay, R., & Whitehouse, H. (2015). Religion and morality. Psychological Bulletin, 141(2), 447.
MacKinnon, S., & Pearson, S. (2018). Update: Your professional duties around overdose response kits. The Advocate, (Winter). https://acsw.in1touch.org/uploaded/web/website/Naloxone%20Update%20ACSW%20Advocate%20Winter%202018-pages-12-13.pdf
Pauly, B. (2008). Harm reduction through a social justice lens. International Journal of Drug Policy, 19, 4–10.
Pauly, B., Goldstone, I., McCall, J., Gold, F., & Payne, S. (2007). The ethical, legal and social context of harm reduction. Canadian Nurse, 103, 19–23.
Pauly, B. Varcoe, C., & Stork, J. (2012). Framing the issues: Moral distress in health care. HEC Forum, 24, 1–11. https://doi.org/10.1007/s10730-012-9176-y
Smye, V. L., Browne, A. J., Varcoe, C., & Josewski, V. (2011). Harm reduction, methadone maintenance treatment and the root causes of health and social inequities: An intersectional lens in the Canadian context. Harm Reduction Journal, 8, 17.
Zalta, E. N. (Ed.). (2017). The Stanford encyclopedia of philosophy. Stanford University. https://plato.stanford.edu/index.html